SCHEMBL10704394

SCHEMBL10704394

C=C1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(OC(=O)CCCCC)C(C)=O)[C@]2(C)C1=CC(=O)[C@@H]1C[C@@H]12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 6/20 0.55
▸ NR3C1 P04150 5/20 0.55
▸ PGR P06401 4/20 0.55
▸ LMNA P02545 4/20 0.55
▸ MAPT P10636 2/20 0.55
▸ PDE3A Q14432 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ HIF1A Q16665 2/20 0.55
▸ NPSR1 Q6W5P4 2/20 0.55
▸ HPGD P15428 1/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ MLNR O43193 1/20 0.55
▸ NR1I2 O75469 1/20 0.55
▸ ADORA3 P0DMS8 1/20 0.55
▸ HTT P42858 1/20 0.55
▸ SLC6A3 Q01959 1/20 0.55
▸ PDE4D Q08499 1/20 0.55
▸ AR P10275 3/20 0.51
▸ ALDH1A1 P00352 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10706225 0.98 NR3C1 (0.52) CYP3A4NR3C1PGRLMNAMAPT
SCHEMBL10705486 0.94 NR3C1 (0.53) CYP3A4NR3C1PGRLMNAMAPT
SCHEMBL10703057 0.91 CYP3A4 (0.54) CYP3A4NR3C1PGRLMNAMAPT
SCHEMBL10703140 0.87 CYP3A4 (0.65) CYP3A4NR3C1PGRLMNAMAPT
SCHEMBL10704042 0.85 CYP3A4 (0.56) CYP3A4NR3C1PGRLMNAMAPT
SCHEMBL10705476 0.84 NR3C1 (0.69) CYP3A4NR3C1PGRLMNAMAPT
SCHEMBL10706361 0.83 CYP3A4 (0.56) CYP3A4NR3C1PGRLMNAMAPT
SCHEMBL11800114 0.83 CYP3A4 (0.55) CYP3A4NR3C1PGRLMNAMAPT
SCHEMBL10705817 0.83 CYP3A4 (0.53) CYP3A4NR3C1PGRLMNAMAPT
SCHEMBL11799756 0.83 CYP3A4 (0.55) CYP3A4NR3C1PGRLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP claimed
EP-0153270-A2 1-Alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-08-28 — — EP claimed
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP disclosed
US-4670427-A ANTIANDROGENS SCHERING AKTIENGESELLSCHAFT (DE) 1987-06-02 — — US disclosed
Send feedback